Cargando…

Perspectives on clinical use of bioimpedance in hemodialysis: focus group interviews with renal care professionals

BACKGROUND: Inadequate volume control may be a main contributor to poor survival and high mortality in hemodialysis patients. Bioimpedance measurement has the potential to improve fluid management, but several dialysis centers lack an agreed fluid management policy, and the method has not yet been i...

Descripción completa

Detalles Bibliográficos
Autores principales: Stenberg, Jenny, Henriksson, Catrin, Lindberg, Magnus, Furuland, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966881/
https://www.ncbi.nlm.nih.gov/pubmed/29792174
http://dx.doi.org/10.1186/s12882-018-0907-4
_version_ 1783325527194468352
author Stenberg, Jenny
Henriksson, Catrin
Lindberg, Magnus
Furuland, Hans
author_facet Stenberg, Jenny
Henriksson, Catrin
Lindberg, Magnus
Furuland, Hans
author_sort Stenberg, Jenny
collection PubMed
description BACKGROUND: Inadequate volume control may be a main contributor to poor survival and high mortality in hemodialysis patients. Bioimpedance measurement has the potential to improve fluid management, but several dialysis centers lack an agreed fluid management policy, and the method has not yet been implemented. Our aim was to identify renal care professionals’ perceived barriers and facilitators for use of bioimpedance in clinical practice. METHODS: Qualitative data were collected through four focus group interviews with 24 renal care professionals: dieticians, nephrologists and nurses, recruited voluntarily from a nation-wide selection of hemodialysis centers, having access to a bioimpedance-device. The participants were connected to each other and a moderator via equipment for telemedicine and the sessions were recorded. The interviews were semi-structured, focusing on the participants’ perceptions of use of bioimpedance in clinical practice. Thematic content analysis was performed in consecutive steps, and data were extracted by employing an inductive, interactive, comparative process. RESULTS: Several barriers and facilitators to the use of bioimpedance in clinical practice were identified, and a multilevel approach to examining barriers and incentives for change was found to be applicable to the ideas and categories that arose from the data. The determinants were categorized on five levels, and the different themes of the levels illustrated with quotations from the focus groups participants. CONCLUSIONS: Determinants for use of bioimpedance were identified on five levels: 1) the innovation itself, 2) the individual professional, 3) the patient, 4) the social context and 5) the organizational context. Barriers were identified in the areas of credibility, awareness, knowledge, self-efficacy, care processes, organizational structures and regulations. Facilitators were identified in the areas of the innovation’s attractiveness, advantages in practice, and collaboration. Motivation, team processes and organizational capacities appeared as both barriers and facilitators. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12882-018-0907-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5966881
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59668812018-05-24 Perspectives on clinical use of bioimpedance in hemodialysis: focus group interviews with renal care professionals Stenberg, Jenny Henriksson, Catrin Lindberg, Magnus Furuland, Hans BMC Nephrol Research Article BACKGROUND: Inadequate volume control may be a main contributor to poor survival and high mortality in hemodialysis patients. Bioimpedance measurement has the potential to improve fluid management, but several dialysis centers lack an agreed fluid management policy, and the method has not yet been implemented. Our aim was to identify renal care professionals’ perceived barriers and facilitators for use of bioimpedance in clinical practice. METHODS: Qualitative data were collected through four focus group interviews with 24 renal care professionals: dieticians, nephrologists and nurses, recruited voluntarily from a nation-wide selection of hemodialysis centers, having access to a bioimpedance-device. The participants were connected to each other and a moderator via equipment for telemedicine and the sessions were recorded. The interviews were semi-structured, focusing on the participants’ perceptions of use of bioimpedance in clinical practice. Thematic content analysis was performed in consecutive steps, and data were extracted by employing an inductive, interactive, comparative process. RESULTS: Several barriers and facilitators to the use of bioimpedance in clinical practice were identified, and a multilevel approach to examining barriers and incentives for change was found to be applicable to the ideas and categories that arose from the data. The determinants were categorized on five levels, and the different themes of the levels illustrated with quotations from the focus groups participants. CONCLUSIONS: Determinants for use of bioimpedance were identified on five levels: 1) the innovation itself, 2) the individual professional, 3) the patient, 4) the social context and 5) the organizational context. Barriers were identified in the areas of credibility, awareness, knowledge, self-efficacy, care processes, organizational structures and regulations. Facilitators were identified in the areas of the innovation’s attractiveness, advantages in practice, and collaboration. Motivation, team processes and organizational capacities appeared as both barriers and facilitators. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12882-018-0907-4) contains supplementary material, which is available to authorized users. BioMed Central 2018-05-23 /pmc/articles/PMC5966881/ /pubmed/29792174 http://dx.doi.org/10.1186/s12882-018-0907-4 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Stenberg, Jenny
Henriksson, Catrin
Lindberg, Magnus
Furuland, Hans
Perspectives on clinical use of bioimpedance in hemodialysis: focus group interviews with renal care professionals
title Perspectives on clinical use of bioimpedance in hemodialysis: focus group interviews with renal care professionals
title_full Perspectives on clinical use of bioimpedance in hemodialysis: focus group interviews with renal care professionals
title_fullStr Perspectives on clinical use of bioimpedance in hemodialysis: focus group interviews with renal care professionals
title_full_unstemmed Perspectives on clinical use of bioimpedance in hemodialysis: focus group interviews with renal care professionals
title_short Perspectives on clinical use of bioimpedance in hemodialysis: focus group interviews with renal care professionals
title_sort perspectives on clinical use of bioimpedance in hemodialysis: focus group interviews with renal care professionals
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966881/
https://www.ncbi.nlm.nih.gov/pubmed/29792174
http://dx.doi.org/10.1186/s12882-018-0907-4
work_keys_str_mv AT stenbergjenny perspectivesonclinicaluseofbioimpedanceinhemodialysisfocusgroupinterviewswithrenalcareprofessionals
AT henrikssoncatrin perspectivesonclinicaluseofbioimpedanceinhemodialysisfocusgroupinterviewswithrenalcareprofessionals
AT lindbergmagnus perspectivesonclinicaluseofbioimpedanceinhemodialysisfocusgroupinterviewswithrenalcareprofessionals
AT furulandhans perspectivesonclinicaluseofbioimpedanceinhemodialysisfocusgroupinterviewswithrenalcareprofessionals